Agenda Released for SMi's 9th Annual Event on ADMET

Share Article

SMi Group Ltd is pleased to announce that registration is now live to attend ADMET 2014. With a focus on enhancing drug quality by ADMET optimisation in discovery, the event will take place on 30th June and 1st July in central London.

ADMET | 30TH JUNE & 1ST JULY 2014, London UK


"Great conference…well organised" - Sanofi

The ADMET conference has been an established event in its field for almost a decade. The 9th annual event taking place on 30th June and 1st July in central London, will look to gather industry leading experts to deliver over eighteen case study driven presentations, providing a unique forum to engage with KOL’s and experts active in the field.

ADMET 2014 will enable delegates to gain insights into enhancing drug quality by ADMET optimisation in discovery. It will focus on themes including Predictive ADME, Screening Approaches, Predictive Toxicology, Drug to Drug interactions and emerging issues such as regulatory changes. Click here for the agenda

Previous instalments have received positive feedback from the industry including "Nice mix of attendees" – Grunenthal, "Good conference at general level to update your current knowledge" - Orion Corporation and "Great conference…well organised" - Sanofi

The speaker line-up includes:

  •     Natalie Gobeau, Metabolism and Pharmacokinetics, Novartis
  •     Dietmar-Weitz, Lab Head/ADME In Vitro Systems, Sanofi-Aventis
  •     Sarah Baldwin, In Vitro DMPK Manager, GSK
  •     Chris Powell, VP Safety Assessment, GSK
  •     Georg Schmitt, Head of Toxicology, Roche Pharmaceuticals
  •     Richard Thompson, Principal Scientist, AstraZeneca
  •     Franck Atienzar, Associate Director, In Vitro and In Silico Toxicology, UCB
  •     Adina Tocoian, Senior Clinical Pharmacologist, UCB
  •     David Fairman, Senior Clinical Pharmacokinetist, MedImmune

The conference will aim to provide attendees with:

  •     A comprehensive look into integrating ADME and toxicity data to enhance the prediction and understanding of drug safety in humans
  •     Updates on drug transporters including the evolving transporter strategies in drug development and the different roles of drug transporters in R&D
  •     Presentations exploring the ADME properties of peptides in drug discovery
  •     An evaluation into the challenges of making an accurate human dose prediction

For those that are interested, there is currently a £300 early bird discount available on the event website with a deadline of 31st March. For further details on the conference and to download a brochure, visit

ADMET | Enhancing drug quality by ADMET optimisation in discovery
30TH JUNE – 1ST JULY 2014
The Marriott Regents Park Hotel, London UK
@smipharm #admet

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sonal Patel

Julia Rotar
Visit website